Renal Cancer
A Near Infrared-Peptide Probe with Tumor-Specific Excretion Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma.
January 20, 2020
TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma.
January 20, 2020
Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines.
January 20, 2020
Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma.
January 17, 2020
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
January 17, 2020
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
January 16, 2020
NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.
January 15, 2020
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
January 15, 2020
Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma.
January 14, 2020
Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
January 14, 2020
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.
January 14, 2020
Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
January 13, 2020